key: cord-0781772-6lq2279q
authors: Marongiu, Francesco; Grandone, Elvira; Barcellona, Doris
title: Pulmonary thrombosis in 2019‐nCoV pneumonia?
date: 2020-04-15
journal: J Thromb Haemost
DOI: 10.1111/jth.14818
sha: 90d97a365318167e1ba72fc4d3cc13f965da08b0
doc_id: 781772
cord_uid: 6lq2279q

nan

Last February, the Journal of Thrombosis and Haemostasis pub- The purpose of this study was to describe the characteristics of coagulative tests in these patients. At admission, the deceased patients showed higher levels of D-dimer and fibrin degradation products other than significantly prolonged prothrombin time (PT) than survivors. International Society on Thrombosis and Haemostasis (ISTH) criteria for disseminated intravascular coagulation (DIC) were present in 71.4% of non-survivors and in 0.6% of survivors. The total mortality rate was 11.5%.

The authors suggested an activation of blood coagulation with secondary fibrinolysis. However, they reported only laboratory findings of DIC but no bleeding was mentioned, indicating that there was not an overt DIC.

Our hypothesis is that the abnormal laboratory findings could be an expression of a local DIC, ie, a pulmonary vascular thrombosis with subsequent activation of fibrinolysis. The concept of pulmonary thrombosis has been recently proposed for conditions such as pneumonia, asthma, and chronic obstructive pulmonary disease. 2 It is known that viral diseases such as those from EBOLA and cytomegaloviruses can induce DIC. 3, 4 Therefore, it is not surprising that 2019-nCoV could be capable of doing the same.

The development of DIC is due to the activation of cytokine-producing monocytes, such as interleukin 6 and tumor necrosis factor, which in turn induce activation of the endothelial cells and tissue factor that triggers the blood coagulation cascade. 5 The activation of blood coagulation is essential in counteracting viral infections along with the immune system trapping viruses by forming a fibrin network, thus limiting their dissemination. 6 However, a massive inflammatory and coagulative response is dangerous because it can lead to a local thrombosis in the lungs. 7 Acute respiratory distress syndrome (ARDS) has been de- F I G U R E 1 A drawing to illustrate a possible mechanism inducing pulmonary thrombosis. After nCoV infection monocytes and released cytokines can provoke interstitial inflammation, endothelial damage, and blood coagulation activation. Tissue factor is crucial in that it can be either exposed by monocytes, damaged endothelial cells or activated by the cytokines' burden. The final result may be thrombin production and consequent alveolar and capillary thrombosis. C, cytokines; DEC, damaged endothelial cells; M, monocyte; nCoV, novel coronavirus; P, pneumocyte; TF, tissue factor; Th, thrombin 

The coagulation system in host defense

Inhibition of the extrinsic or intrinsic coagulation pathway during pneumonia-derived sepsis

Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China

Acute respiratory distress syndrome as an organ phenotype of vascular microthrombotic disease: based on hemostatic theory and endothelial molecular pathogenesis

Fondaparinux pentasaccharide reduces sepsis coagulopathy and promotes survival in the baboon model of Escherichia coli sepsis